An examination of regenerative medicine-based strategies for the urinary bladder

Regenerative Medicine

Volumn 6, Issue 5, 2011, Pages 583-598

  Sharma, Arun K ^a,b,c  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

elastomers; nanotechnology; regenerative medicine; scaffolds; stem cells; urinary bladder

Indexed keywords

AMPHOPHILE; BIOMATERIAL; BLADDER ACELLULAR MATRIX; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ELASTOMER; HYALURONIC ACID; MACROGOL; POLY(1,8 OCTANEDIOL CO CITRATE); POLYGLACTIN; POLYGLYCOLIC ACID; TISSUE SCAFFOLD; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; BLADDER INNERVATION; BLADDER RECONSTRUCTION; BLADDER REGENERATION; BLADDER SURGERY; BLADDER TISSUE ENGINEERING; CELL DIFFERENTIATION; CELL TYPE; CYTOLOGY; ELASTICITY; EMBRYONIC STEM CELL; ENTEROCYSTOPLASTY; HUMAN; HYDROGEL; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL; TISSUE ENGINEERING; TISSUE REGENERATION; UROTHELIUM; YOUNG MODULUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; HYDROGELS; MULTIPOTENT STEM CELLS; NANOTECHNOLOGY; REGENERATION; REGENERATIVE MEDICINE; TISSUE ENGINEERING; TISSUE SCAFFOLDS; URINARY BLADDER;

EID: 80052893565     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.11.47     Document Type: Review

References (141)

1. Egerton FN. A history of the ecological sciences, Part 21: Raumur and his history of insects. Bull. Ecol. Soc. Am. 87, 212-224 (2006).
2. Vejdovsky V, Heinc A. Fifty years since first transparent keratoplasty. Cesk Oftalmol. 12, 161-164 (1956).
3. Guild WR, Harrison JH, Merrill JP, Murray J. Successful homotransplantation of the kidney in an identical twin. Trans. Am. Clin. Climatol. Assoc. 67, 167-173 (1995).
4. Oberpenning F, Meng J, Yoo JJ, Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat. Biotechnol. 17, 149-155 (1999). (Pubitemid 29072538)
5. Sutherland RS, Baskin LS, Hayward SW, Cunha GR. Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix. J. Urol. 156, 571-577 (1996). (Pubitemid 126444879)
6. de Jong TP, Chrzan R, Klijn AJ, Dik P. Treatment of the neurogenic bladder in spina bifida. Pediatr. Nephrol. 23, 889-896 (2008).
7. Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood DP Jr. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology 76, 671-675 (2010).
8. Shin K, Lee J, Guo N, et al. Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature 472, 110-114 (2011).
9. Rickard A, Dorokhov N, Ryerse J, Klumpp DJ, McHowat J. Characterization of tight junction proteins in cultured human urothelial cells. In Vitro Cell Dev. Biol. Anim. 44, 261-267 (2008).
10. Southgate J, Varley CL, Garthwaite MA, et al. Differentiation potential of urothelium from patients with benign bladder dysfunction. BJU Int. 99, 1506-1516 (2007). (Pubitemid 47164804)
11. Evren S, Loai Y, Antoon R, et al. Urinary bladder tissue engineering using natural scaffolds in a porcine model: role of Toll-like receptors and impact of biomimetic molecules. Cells Tissues Organs 192, 250-261 (2010).
12. Burkhard FC, Lemack GE, Zimmern PE, Lin VK, McConnell JD. Contractile protein expression in bladder smooth muscle is a marker of phenotypic modulation after outlet obstruction in the rabbit model. J. Urol. 165, 963-967 (2001). (Pubitemid 32156332)
13. Kanematsu A, Ramachandran A, Adam RM. GATA-6 mediates human bladder smooth muscle differentiation: involvement of a novel enhancer element in regulating a-smooth muscle actin gene expression. Am. J. Physiol. Cell Physiol. 293, C1093-C1102 (2007). (Pubitemid 47437382)
14. Sharma AK, Fuller NJ, Sullivan RR, et al. Defined populations of bone marrow derived mesenchymal stem and endothelial progenitor cells for bladder regeneration. J. Urol. 182, 1898-1905 (2009).
15. Aitken KJ, Bägli DJ. The bladder extracellular matrix. Part I: architecture, development and disease. Nat. Rev. Urol. 6, 596-611 (2009).
16. Greenland JE, Brading AF. Urinary bladder blood flow changes during the micturition cycle in a conscious pig model. J. Urol. 156, 1858-1861 (1996). (Pubitemid 26344070)
17. Rajangam K, Arnold MS, Rocco MA, Stupp SI. Peptide amphiphile nanostructure- heparin interactions and their relationship to bioactivity. Biomaterials 29, 3298-3305 (2008).
18. Saban MR, Sferra TJ, Davis CA, et al. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment. Am. J. Physiol. Renal Physiol. 299, F1245-F1256 (2010).
19. Park J, Lim E, Back S, et al. Nerve regeneration following spinal cord injury using matrix metalloproteinase-sensitive, hyaluronic acid-based biomimetic hydrogel scaffold containing brain-derived neurotrophic factor. J. Biomed. Mater. Res. A 93, 1091-1099 (2010).
20. Xiao CG, Du MX, Dai C, et al. An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J. Urol. 170, 1237-1241 (2003). (Pubitemid 37108123)
21. Knapp PM, Lingeman JE, Siegel YI, Badylak SF, Demeter RJ. Biocompatibility of small-intestinal submucosa in urinary tract as augmentation cystoplasty graft and injectable suspension. J. Endourol. 8, 125-130 (1994). (Pubitemid 24305783)
22. Kropp BP, Badylak S, Thor KB. Regenerative bladder augmentation: a review of the initial preclinical studies with porcine small intestinal submucosa. Adv. Exp. Med. Biol. 385, 229-235 (1995).
23. Kropp BP, Sawyer BD, Shannon HE, et al. Characterization of small intestinal submucosa regenerated canine detrusor: assessment of reinnervation, in vitro compliance and contractility. J. Urol. 156, 599-607 (1996). (Pubitemid 126444884)
24. Jankowski R, Pruchnic R, Hiles M, Chancellor MB. Advances toward tissue engineering for the treatment of stress urinary incontinence. Rev. Urol. 6, 51-57 (2004).
25. Xie H, Shaffer BS, Wadia Y, Gregory KW. Use of reconstructed small intestine submucosa for urinary tract replacement. ASAIO J. 46, 268-272 (2000). (Pubitemid 30308118)
26. Parshotam Kumar G, Barker A, Ahmed S, Gerath J, Orford J. Urinary bladder auto augmentation using INTEGRA and SURGISIS: an experimental model. Pediatr. Surg. Int. 26, 275-280 (2010).
27. Ashley RA, Roth CC, Palmer BW, et al. Regional variations in small intestinal submucosa evoke differences in inflammation with subsequent impact on tissue regeneration in the rat bladder augmentation model. BJU Int. 105, 1462-1468 (2010).
28. Ashley RA, Palmer BW, Schultz AD, et al. Leukocyte inflammatory response in a rat urinary bladder regeneration model using porcine small intestinal submucosa scaffold. Tissue Eng. Part A 15, 3241-3246 (2009).
29. Kropp BP, Cheng EY, Lin HK, Zhang Y. Reliable and reproducible bladder regeneration using unseeded distal small intestinal submucosa. J. Urol. 172, 1710-1713 (2004). (Pubitemid 39245025)
30. Dahms SE, Piechota HJ, Dahiya R, Lue TF, Tanagho EA. Composition and biomechanical properties of the bladder acellular matrix graft: comparative analysis in rat, pig and human. Br. J. Urol. 82, 411-419 (1998). (Pubitemid 28434618)
31. Piechota HJ, Dahms SE, Probst M, et al. Functional rat bladder regeneration through xenotransplantation of the bladder acellular matrix graft. Br. J. Urol. 81, 548-559 (1998). (Pubitemid 28316584)
32. Piechota HJ, Gleason CA, Dahms SE, et al. Bladder acellular matrix graft: in vivo functional properties of the regenerated rat bladder. Urol. Res. 27, 206-213 (1999). (Pubitemid 29287600)
33. Loai Y, Yeger H, Coz C, et al. Bladder tissue engineering: tissue regeneration and neovascularization of HA-VEGF-incorporated bladder acellular constructs in mouse and porcine animal models. J. Biomed. Mater. Res. A 94, 1205-1215 (2010).
34. Brown AL, Farhat W, Merguerian PA, et al. 22 week assessment of bladder acellular matrix as a bladder augmentation material in a porcine model. Biomaterials 23, 2179-2190 (2002). (Pubitemid 34226578)
35. Herrmann JB, Kelly RJ, Higgins GA. Polyglycolic acid sutures. Laboratory and clinical evaluation of a new absorbable suture material. Arch. Surg. 100, 486-490 (1970).
36. McCarthy WH. A new synthetic absorbable suture material: a clinical trial of polyglycolic acid suture in general surgery. Aust. NZ J. Surg. 39, 422-424 (1970).
37. Lichtenstein IL. Polyglycolic acid (PGA) sutures. JAMA 214(4), 760 (1970).
38. Clark CG, Harris J, Elmasri S, Wyllie JH, Dow J. Polyglycolic-acid sutures and catgut in colonic anastomoses. A controlled clinical trial. Lancet 2, 1006-1007 (1972).
39. Wang L, Dormer NH, Bonewald LF, Detamore MS. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng. Part A 16, 1937-1948 (2010).
40. Yang J, Cao C, Wang W, et al. Proliferation and osteogenesis of immortalized bone marrow-derived mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture. J. Biomed. Mater. Res. A 92, 817-829 (2010).
41. Olson HE, Rooney GE, Gross L, et al. Neural stem cell- and Schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng. Part A 15, 1797-1805 (2009).
42. Cuddihy MJ, Kotov NA. Poly(lactic-co-glycolic acid) bone scaffolds with inverted colloidal crystal geometry. Tissue Eng. Part A 14, 1639-1649 (2008).
43. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 126, 677-689 (2006). (Pubitemid 44233625)
44. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 367, 1241-1246 (2006).
45. Ceonzo K, Gaynor A, Shaffer L, et al. Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. Tissue Eng. 12, 301-308 (2006).
46. Peltoniemi HH, Hallikainen D, Toivonen T, Helevirta P, Waris T. SR-PLLA and SR-PGA miniscrews: biodegradation and tissue reactions in the calvarium and dura mater. J. Craniomaxillofac. Surg. 27, 42-50 (1999). (Pubitemid 29131405)
47. Weiler A, Helling HJ, Kirch U, Zirbes TK, Rehm KE. Foreign-body reaction and the course of osteolysis after polyglycolide implants for fracture fixation: experimental study in sheep. J. Bone Joint Surg. Br. 78, 369-376 (1996).
48. Kohn DH, Sarmadi M, Helman JI, Krebsbach PH. Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. J. Biomed. Mater. Res. 60, 292-299 (2002). (Pubitemid 34194591)
49. Middleton JC, Tipton AJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 21, 2335-2346 (2000).
50. Heise RL, Ivanova J, Parekh A, Sacks MS. Generating elastin-rich small intestinal submucosa-based smooth muscle constructs utilizing exogenous growth factors and cyclic mechanical stimulation. Tissue Eng. Part A 15, 3951-3960 (2009).
51. Khalilian M, Navidbakhsh M, Valojerdi MR, Chizari M, Yazdi PE. Estimating Youngs modulus of zona pellucida by micropipette aspiration in combination with theoretical models of ovum. J. R. Soc. Interface 7, 687-694 (2010).
52. Min SH, Ferracane J, Lee IB. Effect of shrinkage strain, modulus, and instrument compliance on polymerization shrinkage stress of light-cured composites during the initial curing stage. Dent. Mater. 26, 1024-1033 (2010).
53. Rivadulla F, Baaobre-Lapez M, Quintela CX, et al. Reduction of the bulk modulus at high pressure in CrN. Nat. Mater. 8, 947-951 (2009).
54. Nicholson JW. The Chemistry of Polymers (2nd Edition). Royal Society of Chemistry, Cambridge, UK (2003).
55. Boretos JW, Pierce WS. Segmented polyurethane: a new elastomer for biomedical applications. Science 158, 1481-1482 (1967).
56. Wagner M, Ruel G, Teresi J, Kayser K. The use of spandex as a vascular patch graft material. Surg. Gynecol. Obstet. 127, 805-807 (1968).
57. Capozzi A, Pennisi VR. Clinical experience with polyurethane-covered gel-filled mammary prostheses. Plast. Reconstr. Surg. 68, 512-520 (1981). (Pubitemid 11022410)
58. Pattison MA, Webster TJ, Haberstroh KM. Select bladder smooth muscle cell functions were enhanced on three-dimensional, nano-structured poly(ether urethane) scaffolds. J. Biomater. Sci. Polym. Ed. 17, 1317-1332 (2006). (Pubitemid 44650634)
59. Thapa A, Miller DC, Webster TJ, Haberstroh KM. Nano-structured polymers enhance bladder smooth muscle cell function. Biomaterials 24, 2915-2926 (2003). (Pubitemid 36542991)
60. Vance RJ, Miller DC, Thapa A, Haberstroh KM, Webster TJ. Decreased fibroblast cell density on chemically degraded poly-lactic-co-glycolic acid, polyurethane, and polycaprolactone. Biomaterials 25, 2095-2103 (2004). (Pubitemid 38102410)
61. Danielsson C, Ruault S, Simonet M, Neuenschwander P, Frey P. Polyesterurethane foam scaffold for smooth muscle cell tissue engineering. Biomaterials 27, 1410-1415 (2006). (Pubitemid 41739566)
62. Nieponice A, Soletti L, Guan J, et al. Development of a tissue-engineered vascular graft combining a biodegradable scaffold, muscle-derived stem cells and a rotational vacuum seeding technique. Biomaterials 29, 825-833 (2008). (Pubitemid 350266044)
63. Jiang X, Yu F, Wang Z, et al. Fabrication and characterization of waterborne biodegradable polyurethanes: 3-dimensional porous scaffolds for vascular tissue engineering. J. Biomater. Sci. Polym. Ed. 21, 1637-1652 (2010).
64. Uttayarat P, Perets A, Li M, et al. Micropatterning of three-dimensional electrospun polyurethane vascular grafts. Acta Biomater. 6, 4229-4237 (2010).
65. Grasl C, Bergmeister H, Stoiber M, Schima H, Weigel G. Electrospun polyurethane vascular grafts: in vitro mechanical behavior and endothelial adhesion molecule expression. J. Biomed. Mater. Res. A 93, 716-723 (2010).
66. Yang J, Webb AR, Pickerill SJ, Hageman G, Ameer GA. Synthesis and evaluation of poly(diol citrate) biodegradable elastomers. Biomaterials 27, 1889-1898 (2006). (Pubitemid 41759483)
67. Motlagh D, Allen J, Hoshi R, et al. Hemocompatibility evaluation of poly(diol citrate) in vitro for vascular tissue engineering. J. Biomed. Mater. Res. A 82, 907-916 (2007). (Pubitemid 47312906)
68. Zhao H, Serrano MC, Popowich DA, Kibbe MR, Ameer GA. Biodegradable nitric oxide-releasing poly(diol citrate) elastomers. J. Biomed. Mater. Res. A 93, 356-363 (2010).
69. Sharma AK, Hota PV, Matoka DJ, et al. Urinary bladder smooth muscle regeneration utilizing bone marrow derived mesenchymal stem cell seeded elastomeric poly(1,8- octanediol-co-citrate) based thin films. Biomaterials 31, 6207-6217 (2010).
70. Leipzig ND, Wylie RG, Kim H, Shoichet MS. Differentiation of neural stem cells in three-dimensional growth factor-immobilized chitosan hydrogel scaffolds. Biomaterials 32, 57-64 (2011).
71. Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA. Hydrogels in regenerative medicine. Adv. Mater. 21, 3307-3329 (2009).
72. Gyawali D, Nair P, Zhang Y, et al. Citric acid-derived in situ crosslinkable biodegradable polymers for cell delivery. Biomaterials 31, 9092-9105 (2010).
73. Ramseyer P, Micol LA, Engelhardt EM, et al. In vivo study of an injectable poly(acrylonitrile)-based hydrogel paste as a bulking agent for the treatment of urinary incontinence. Biomaterials 31, 4613-4619 (2010).
74. Adelöw CA, Frey P. Synthetic hydrogel matrices for guided bladder tissue regeneration. Methods Mol. Med. 140, 125-140 (2007).
75. Adelöw C, Segura T, Hubbell JA, Frey P. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials 29, 314-326 (2008). (Pubitemid 350060978)
76. Kyle S, Aggeli A, Ingham E, McPherson MJ. Recombinant self-assembling peptides as biomaterials for tissue engineering. Biomaterials 31, 9395-9405 (2010).
77. Capito RM, Azevedo HS, Velichko YS, Mata A, Stupp SI. Self-assembly of large and small molecules into hierarchically ordered sacs and membranes. Science 319, 1812-1816 (2008). (Pubitemid 351451586)
78. Hartgerink JD, Beniash E, Stupp SI. Self-assembly and mineralization of peptide-amphiphile nanofibers. Science 294, 1684-1688 (2001). (Pubitemid 33104832)
79. Jakab K, Norotte C, Marga F, et al. Tissue engineering by self-assembly and bio-printing of living cells. Biofabrication 2, 022001 (2010).
80. Chow LW, Wang LJ, Kaufman DB, Stupp SI. Self-assembling nanostructures to deliver angiogenic factors to pancreatic islets. Biomaterials 31, 6154-6161 (2010).
81. Standley SM, Toft DJ, Cheng H, et al. Induction of cancer cell death by self-assembling nanostructures incorporating a cytotoxic peptide. Cancer Res. 70, 3020-3026 (2010).
82. Stendahl JC, Wang LJ, Chow LW, Kaufman DB, Stupp SI. Growth factor delivery from self-assembling nanofibers to facilitate islet transplantation. Transplantation 86, 478-481 (2008).
83. Silva GA, Czeisler C, Niece KL, et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303, 1352-1355 (2004). (Pubitemid 38269424)
84. Rajangam K, Behanna HA, Hui MJ, et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett. 6, 2086-2090 (2006). (Pubitemid 44555259)
85. Webber MJ, Han X, Murthy SN, et al. Capturing the stem cell paracrine effect using heparin-presenting nanofibres to treat cardiovascular diseases. J. Tissue Eng. Regen. Med. 4, 600-610 (2010).
86. Chow LW, Bitton R, Webber MJ, et al. A bioactive self-assembled membrane to promote angiogenesis. Biomaterials 32, 1574-1582 (2011).
87. Mondalek FG, Ashley RA, Roth CC, et al. Enhanced angiogenesis of modified porcine small intestinal submucosa with hyaluronic acid-poly(lactide-co- glycolide) nanoparticles: from fabrication to preclinical validation. J. Biomed. Mater. Res. A 94, 712-719 (2010).
88. Roth CC, Mondalek FG, Kibar Y, et al. Bladder regeneration in a canine model using hyaluronic acid-poly(lactic-co-glycolic-acid) nanoparticle modified porcine small intestinal submucosa. BJU 108, 148-155 (2011).
89. Xiong N, Zhang Z, Huang J, et al. VEGF-expressing human umbilical cord mesenchymal stem cells, an improved therapy strategy for Parkinsons disease. Gene Ther. 18, 394-402 (2011).
90. Kadam SS, Bhonde RR. Islet neogenesis from the constitutively nestin expressing human umbilical cord matrix derived mesenchymal stem cells. Islets 2, 112-120 (2010).
91. Kan I, Barhum Y, Melamed E, Offen D. Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev. 7, 404-412 (2011).
92. Choi YH, Kurtz A, Stamm C. Mesenchymal stem cells for cardiac cell therapy. Hum. Gene Ther. 22, 3-17 (2011).
93. Chistiakov DA. Endogenous and exogenous stem cells: a role in lung repair and use in airway tissue engineering and transplantation. J. Biomed. Sci. 17, 92 (2010).
94. Vodyanik MA, Yu J, Zhang X, et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7, 718-729 (2010).
95. Inamura M, Kawabata K, Takayama K, et al. Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX. Mol. Ther. 19, 400-407 (2011).
96. Bilousova G, Hyun Jun D, King KB, et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vitro. Stem Cells 29, 206-216 (2011).
97. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 (1999). (Pubitemid 29282067)
98. Portmann-Lanz CB, Schoeberlein A, Portmann R, et al. Turning placenta into brain: placental mesenchymal stem cells differentiate into neurons and oligodendrocytes. Am. J. Obstet. Gynecol. 202, 294.e1-294.e11 (2010).
99. Tark KC, Hong JW, Kim YS, et al. Effects of human cord blood mesenchymal stem cells on cutaneous wound healing in leprdb mice. Ann. Plast. Surg. 65, 565-572 (2010).
100. Long X, Olszewski M, Huang W, Kletzel M. Neural cell differentiation in vitro from adult human bone marrow mesenchymal stem cells. Stem Cells Dev. 14, 65-69 (2005). (Pubitemid 40328249)
101. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet b-cells. World J. Gastroenterol. 10, 3016-3020 (2004). (Pubitemid 39303055)
102. Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb. Exp. Pharmacol. 180, 195-218 (2007).
103. Sharma AK, Bury MI, Marks AJ, et al. A non-human primate model for urinary bladder regeneration utilizing autologous sources of bone marrow derived mesenchymal stem cells. Stem Cells 29, 241-250. (2011).
104. Lee MJ, Jung J, Na KH, et al. Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4-injured liver: potential application to the treatment of hepatic diseases. J. Cell Biochem. 111, 1453-1463 (2010).
105. Ripoll CB, Flaat M, Klopf-Eiermann J, et al. Mesenchymal-lineage stem cells have pronounced anti-inflammatory effects in the twitcher mouse model of Krabbes disease. Stem Cells 29, 67-77 (2011).
106. Pilz GA, Ulrich C, Ruh M, et al. Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev. 20, 635-646 (2011).
107. Jansen BJ, Gilissen C, Roelofs H, et al. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev. 19, 481-490 (2010).
108. Jack GS, Zhang R, Lee M, et al. Urinary bladder smooth muscle engineered from adipose stem cells and a three dimensional synthetic composite. Biomaterials 30, 3259-3270 (2009).
109. Zhu WD, Xu YM, Feng C, et al. Bladder reconstruction with adipose-derived stem cell-seeded bladder acellular matrix grafts improve morphology composition. World J. Urol. 28, 493-498 (2010).
110. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634-7638 (1981). (Pubitemid 12186197)
111. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156 (1981). (Pubitemid 11050741)
112. Doetschman T, Williams P, Maeda N. Establishment of hamster blastocyst-derived embryonic stem (ES) cells. Dev. Biol. 127, 224-227 (1988).
113. Iannaccone PM, Taborn GU, Garton RL, Caplice MD, Brenin DR. Pluripotent embryonic stem cells from the rat are capable of producing chimeras. Dev. Biol. 163, 288-292 (1994). (Pubitemid 24188894)
114. Thomson JA, Kalishman J, Golos TG, et al. Isolation of a primate embryonic stem cell line. Proc. Natl Acad. Sci. USA 15, 7844-7848 (1995).
115. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (1998). (Pubitemid 28516247)
116. Klimchenko O, Di Stefano A, Geoerger B, et al. Monocytic cells derived from human embryonic stem cells and fetal liver share common differentiation pathways and homeostatic functions. Blood 17, 3065-3075 (2011).
117. Vodyanik MA, Yu J, Zhang X, et al. A mesoderm-derived precursor for mesenchymal stem and endothelial cells. Cell Stem Cell 7, 718-729 (2010).
118. Kraehenbuehl TP, Ferreira LS, Hayward AM, et al. Human embryonic stem cell-derived microvascular grafts for cardiac tissue preservation after myocardial infarction. Biomaterials 32, 1102-1109 (2011).
119. Spence JR, Mayhew CN, Rankin SA, et al. Directed differentiation of human pluripotent stem cells into intestinal tissue in vitro. Nature 470, 105-109 (2011).
120. Lakshmanan Y, Frimberger D, Gearhart JD, Gearhart JP. Human embryoid body-derived stem cells in co-culture with bladder smooth muscle and urothelium. Urology 65, 821-826 (2005). (Pubitemid 40523045)
121. Frimberger D, Morales N, Shamblott M, et al. Human embryoid body-derived stem cells in bladder regeneration using rodent model. Urology 65, 827-832 (2005). (Pubitemid 40523046)
122. Frimberger D, Morales N, Gearhart JD, et al. Human embryoid body-derived stem cells in tissue engineering-enhanced migration in co-culture with bladder smooth muscle and urothelium. Urology 67, 1298-1303 (2006). (Pubitemid 43818058)
123. Oottamasathien S, Wang Y, Williams K, et al. Directed differentiation of embryonic stem cells into bladder tissue. Dev. Biol. 304, 556-566 (2007). (Pubitemid 46527566)
124. Thomas JC, Oottamasathien S, Makari JH, et al. Temporal-spatial protein expression in bladder tissue derived from embryonic stem cells. J. Urol. 180, 1784-1789 (2008).
125. Mauney JR, Ramachandran A, Yu RN, et al. All-trans retinoic acid directs urothelial specification of murine embryonic stem cells via GATA4/6 signaling mechanisms. PLoS One 5, e11513 (2010).
126. Ketola I, Rahman N, Toppari J, et al. Expression and regulation of transcription factors GATA-4 and GATA-6 in developing mouse testis. Endocrinology 40, 1470-1480 (1999). (Pubitemid 29104254)
127. van Berlo JH, Elrod JW, van den Hoogenhof MM, et al. The transcription factor GATA-6 regulates pathological cardiac hypertrophy. Circ. Res. 107, 1032-1040 (2010).
128. Knoepfler PS. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27, 1050-1056 (2009).
129. Matsuda R, Yoshikawa M, Kimura H, et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant. 18, 39-54 (2009).
130. Strauss S. Geron trial resumes, but standards for stem cell trials remain elusive. Nat. Biotechnol. 10, 989-990 (2010).
131. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
132. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007). (Pubitemid 350138099)
133. Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
134. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375-386 (2010).
135. Somers A, Jean JC, Sommer CA, et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28, 1728-1740 (2010).
136. Ebert AD, Yu J, Rose FF Jr, et al. Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280 (2009).
137. Mayshar Y, Ben-David U, Lavon N, et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521-531 (2010).
138. Pick M, Stelzer Y, Bar-Nur O, et al. Clone-and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27, 2686-2690.
139. Ben-David U, Benvenisty N, Mayshar Y. Genetic instability in human induced pluripotent stem cells: classification of causes and possible safeguards. Cell Cycle 9, 4603-4604 (2010).
140. Jayo MJ, Jain D, Ludlow JW, et al. Long-term durability, tissue regeneration and neo-organ growth during skeletal maturation with a neo-bladder augmentation construct. Regen. Med. 3(5), 671-682 (2008).
141. Turner A, Subramanian R, Thomas DF, et al. Transplantation of autologous differentiated urothelium in an experimental model of composite cystoplasty. Eur. Urol. 59, 447-454 (2011).